Transpire Bio is a US-based, clinical-stage, biopharmaceutical company headquartered in Florida. Our goal is to unlock new clinical opportunities to better serve patients and healthcare providers by applying our inhalation technologies to high-potential therapeutic areas underserved by current therapies.
Our team includes leading minds in the inhalation space, with our leadership team having been involved with over half of the approved innovative inhaled drugs currently on the US market.